Interaction of C1q with DNA

Molecular Immunology
M R van Schravendijk, R A Dwek

Abstract

With the aim of clarifying the relationship between the activation of the first component of complement (C1) by immunoglobulin and by polyanions, the mode of interaction of C1q with DNA was investigated by structural and inhibition studies. DNA inhibits C1q binding to IgG immune complexes (ICs) through binding to C1q rather than to IgG, as seen from two lines of evidence. Firstly, DNA does not bind to ICs under conditions where full binding to C1q is observed. Secondly, at I - 0.15, DNA inhibits more strongly when mixed first with C1q rather than with ICs. The inhibition of C1q-IgG binding by DNA is subject to kinetic factors. Firstly, DNA is not an effective inhibitor if added after C1q has bound to ICs. This at least in part reflects a portion of the IgG-bound C1q that exchanges only very slowly with free C1q. Secondly, the relative rates of association of C1q to DNA and ICs at different ionic strengths are important in determining whether inhibition is observed. The existence of a kinetic effect in the inhibition by DNA means that inhibition experiments cannot be used to establish whether DNa binds to the same site on C1q as IgG. This question was therefore approached by structural studies. Precipitation of C1q with DNA was ...Continue Reading

References

Feb 1, 1978·Immunochemistry·T Y Lin, D S Fletcher
Jan 1, 1979·Advances in Protein Chemistry·R R Porter, K B Reid
Jan 1, 1978·Biochemical Society Transactions·S B Easterbrook-SmithR A Dwek
Nov 27, 1980·Nature·D R BurtonR A Dwek
Oct 16, 1964·Biochimica Et Biophysica Acta·B H HOFSTEE

❮ Previous
Next ❯

Citations

Jan 1, 1986·Molecular Immunology·J M AlcoleaF Vivanco
Jan 1, 1987·Immunology Letters·R J Vandenberg, S B Easterbrook-Smith
Apr 22, 1986·Biochimica Et Biophysica Acta·A Comis, S B Easterbrook-Smith
Sep 27, 1985·Biochimica Et Biophysica Acta·A Comis, S B Easterbrook-Smith
Apr 25, 1997·Biochemical Pharmacology·D R ShawS Agrawal
Jun 22, 2005·The Journal of Experimental Medicine·Leendert A TrouwAnna M Blom
Apr 21, 1999·Clinical and Experimental Immunology·C E SiegertM R Daha
Oct 20, 1998·Immunobiology·C E Siegert, M R Daha
Jun 17, 2008·Molecular Immunology·Leendert A TrouwAnna M Blom
Oct 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·I E CoremansC G Kallenberg
Apr 20, 2007·Biochimica Et Biophysica Acta·Cecilia L BasiglioAldo D Mottino
Aug 26, 2009·Scandinavian Journal of Immunology·K-Y Su, D S Pisetsky
Jun 3, 2015·Molecular Immunology·Frank J BeurskensLeendert A Trouw
Sep 10, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·O E Bryzgunova, P P Laktionov
Oct 8, 2009·Clinical Science·Cecilia L BasiglioAldo D Mottino
Jun 30, 2015·Journal of Autoimmunity·Rosanne A van SchaarenburgLeendert A Trouw
Aug 13, 1999·Biulleten' eksperimental'noĭ biologii i meditsiny·P P LaktionovV V Vlasov
Aug 11, 2017·Nature Reviews. Rheumatology·Leendert A TrouwAnna M Blom
May 16, 2019·IUBMB Life·Svetlana Tamkovich, Pavel Laktionov
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wei XuCees van Kooten
Jun 3, 1985·FEBS Letters·A Comis, S B Easterbrook-Smith
Apr 30, 2016·Bioorganicheskaia khimiia·S N TamkovichP P Laktionov
Jan 1, 1990·Clinical and Experimental Immunology·M KinoshitaR Yokohari
Aug 1, 1985·Molecular Immunology·A Comis, S B Easterbrook-Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.